Giuffre Randall Michael

Average Profitability
49.77%
Insider Buys Quantity
10
Insider Buys Sum
$605,230.83
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Giuffre Randall Michael

The largest purchase of all time was on 2023-06-23 and amounted to 65000 shares of DiaMedica Therapeutics Inc. for $254,150.

Biography of Giuffre Randall Michael

No biography is available at this moment.

2023-06-23PurchaseDiaMedica Therapeutics Inc.
DMAC
director
65,000
0.2261%
$3.91$254,150-33.18%
2022-12-09PurchaseDiaMedica Therapeutics Inc.
DMAC
director
37,079
0.1402%
$1.43$53,023+57.34%
2022-12-08PurchaseDiaMedica Therapeutics Inc.
DMAC
director
20,000
0.0735%
$1.40$28,000+55.9%
2022-12-07PurchaseDiaMedica Therapeutics Inc.
DMAC
director
22,574
0.086%
$1.40$31,604+61.15%
2022-12-06PurchaseDiaMedica Therapeutics Inc.
DMAC
director
2,300
0.0083%
$1.35$3,105+57.39%
2022-12-01PurchaseDiaMedica Therapeutics Inc.
DMAC
director
46,952
0.1775%
$1.20$56,334+82.08%
2022-11-30PurchaseDiaMedica Therapeutics Inc.
DMAC
director
2,970
0.0112%
$1.19$3,534+82.77%
2022-11-29PurchaseDiaMedica Therapeutics Inc.
DMAC
director
18,125
0.068%
$1.19$21,569+80%
2020-11-20PurchaseDiaMedica Therapeutics Inc.
DMAC
director
15,000
0.0902%
$4.26$63,912+62.31%
2018-12-11PurchaseDiaMedica Therapeutics Inc.
DMAC
director
22,500
0.2097%
$4.00$90,000-8.08%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.